225 related articles for article (PubMed ID: 21469127)
1. Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria.
Bessoles S; Ni M; Garcia-Jimenez S; Sanchez F; Lafont V
Eur J Immunol; 2011 Jun; 41(6):1619-28. PubMed ID: 21469127
[TBL] [Abstract][Full Text] [Related]
2. Vgamma9Vdelta2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella.
Oliaro J; Dudal S; Liautard J; Andrault JB; Liautard JP; Lafont V
J Leukoc Biol; 2005 May; 77(5):652-60. PubMed ID: 15668339
[TBL] [Abstract][Full Text] [Related]
3. NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.
Nedellec S; Sabourin C; Bonneville M; Scotet E
J Immunol; 2010 Jul; 185(1):55-63. PubMed ID: 20511557
[TBL] [Abstract][Full Text] [Related]
4. V gamma 9V delta 2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect.
Ottones F; Dornand J; Naroeni A; Liautard JP; Favero J
J Immunol; 2000 Dec; 165(12):7133-9. PubMed ID: 11120844
[TBL] [Abstract][Full Text] [Related]
5. The innate immune response against Brucella in humans.
Dornand J; Gross A; Lafont V; Liautard J; Oliaro J; Liautard JP
Vet Microbiol; 2002 Dec; 90(1-4):383-94. PubMed ID: 12414158
[TBL] [Abstract][Full Text] [Related]
6. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
[TBL] [Abstract][Full Text] [Related]
7. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
8. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
Todaro M; D'Asaro M; Caccamo N; Iovino F; Francipane MG; Meraviglia S; Orlando V; La Mendola C; Gulotta G; Salerno A; Dieli F; Stassi G
J Immunol; 2009 Jun; 182(11):7287-96. PubMed ID: 19454726
[TBL] [Abstract][Full Text] [Related]
9. Human Vgamma9Vdelta2 T cells: from signals to functions.
Nedellec S; Bonneville M; Scotet E
Semin Immunol; 2010 Aug; 22(4):199-206. PubMed ID: 20447835
[TBL] [Abstract][Full Text] [Related]
10. Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis.
Dudal S; Turriere C; Bessoles S; Fontes P; Sanchez F; Liautard J; Liautard JP; Lafont V
J Immunol; 2006 Oct; 177(8):5533-9. PubMed ID: 17015740
[TBL] [Abstract][Full Text] [Related]
11. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells.
Meraviglia S; Caccamo N; Salerno A; Sireci G; Dieli F
J Immunol; 2010 Aug; 185(3):1770-6. PubMed ID: 20592281
[TBL] [Abstract][Full Text] [Related]
12. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
Bae DS; Hwang YK; Lee JK
Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008
[TBL] [Abstract][Full Text] [Related]
13. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells].
Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338
[TBL] [Abstract][Full Text] [Related]
14. Macrophages and Brucella.
Baldwin CL; Winter AJ
Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands.
Schulz U; Kreutz M; Multhoff G; Stoelcker B; Köhler M; Andreesen R; Holler E
Scand J Immunol; 2010 Oct; 72(4):319-31. PubMed ID: 20883317
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
[TBL] [Abstract][Full Text] [Related]
17. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
Schrama D; Terheyden P; Otto K; Kämmerer U; Bröcker EB; Lühder F; Cosman D; Andersen MH; Becker JC
Eur J Immunol; 2006 Jan; 36(1):65-72. PubMed ID: 16342232
[TBL] [Abstract][Full Text] [Related]
18. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
Poccia F; Gioia C; Martini F; Sacchi A; Piacentini P; Tempestilli M; Agrati C; Amendola A; Abdeddaim A; Vlassi C; Malkovsky M; D'Offizi G
AIDS; 2009 Mar; 23(5):555-65. PubMed ID: 19238075
[TBL] [Abstract][Full Text] [Related]
20. NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
Maccalli C; Pende D; Castelli C; Mingari MC; Robbins PF; Parmiani G
Eur J Immunol; 2003 Jul; 33(7):2033-43. PubMed ID: 12884870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
